Mesenchymal tumors of the gastrointestinal tract with NTRK rearrangements: a clinicopathological, immunophenotypic, and molecular study of eight cases, emphasizing their distinction from gastrointestinal stromal tumor (GIST)
Mazen A. Atiq(Johns Hopkins University), Adrián Mariño‐Enríquez(Harvard University Press), Andrew L. Folpe(Mayo Clinic in Arizona), Brendan C. Dickson(Sinai Health System), Jason L. Hornick(Harvard University), Jessica L. Davis(Indiana University School of Medicine), Jonathan A. Fletcher(Harvard University), Christopher D.�M. Fletcher(Brigham and Women's Hospital)
Cited by 84
Related Papers
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors
|American Journal Of Pathology|2000|716
STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications
|Oncogene|2001|700
Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978–2001: An analysis of 26,758 cases
|International Journal of Cancer|2006|680
KIT Extracellular and Kinase Domain Mutations in Gastrointestinal Stromal Tumors
|American Journal Of Pathology|2000|647